UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 127

Sortiert nach

Predicting atrial fibrillation in primary care using machine learning

PloS one, 2019-11, Vol.14 (11), p.e0224582-e0224582

2019

Volltextzugriff (PDF)

Real-World Associations of Renin-Angiotensin-Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New-Onset Chronic Kidney Disease or Heart Failure in the United Kingdom

Journal of the American Heart Association, 2019-11, Vol.8 (22), p.e012655

2019

Volltextzugriff (PDF)

Validation of a deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from UK Biobank

BMC medicine, 2023-01, Vol.21 (1), p.28-28, Article 28

2023

Volltextzugriff (PDF)

Protecting blinded trials in electronic hospital systems

Clinical trials (London, England), 2022-04, Vol.19 (2), p.231-233

2022

Volltextzugriff (PDF)

Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK

ESC Heart Failure, 2019-04, Vol.6 (2), p.280-290

2019

Volltextzugriff (PDF)

Comparison of Bayesian model averaging and stepwise methods for model selection in logistic regression

Statistics in medicine, 2004-11, Vol.23 (22), p.3451-3467

2004

Volltextzugriff (PDF)

Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink

BMC nephrology, 2018-08, Vol.19 (1), p.211-211, Article 211

2018

Volltextzugriff (PDF)

The value of maintaining normokalaemia and enabling RAASi therapy in chronic kidney disease

BMC nephrology, 2019-01, Vol.20 (1), p.31-31, Article 31

2019

Volltextzugriff (PDF)

Development of delivery indicators and delivery enablers for cardiovascular disease in the UK: a modified Delphi study

BMJ open quality, 2024-02, Vol.13 (1), p.e002634

2024

Volltextzugriff (PDF)

Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe study

European heart journal. Cardiovascular pharmacotherapy, 2021-04, Vol.7 (Supplement_FI1), p.f30-f39

2021

Volltextzugriff (PDF)

Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe)

BMC cardiovascular disorders, 2019-07, Vol.19 (1), p.165-165, Article 165

2019

Volltextzugriff (PDF)

Shining a light on an additional clinical burden: work-related digital communication survey study – COVID-19 impact on NHS staff wellbeing

Humanities & social sciences communications, 2022-12, Vol.9 (1), p.414-414, Article 414

2022

Volltextzugriff (PDF)

Fondaparinux versus Enoxaparin in non–ST-elevation acute coronary syndromes: Short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial

The American heart journal, 2009-05, Vol.157 (5), p.845-852

2009

Volltextzugriff (PDF)

Using machine learning to predict anticoagulation control in atrial fibrillation: A UK Clinical Practice Research Datalink study

Informatics in medicine unlocked, 2021, Vol.25, p.100688, Article 100688

2021

Volltextzugriff (PDF)

Nebulized Recombinant Tissue Plasminogen Activator (rt-PA) for Acute COVID-19-Induced Respiratory Failure: An Exploratory Proof-of-Concept Trial

Journal of clinical medicine, 2023-09, Vol.12 (18), p.5848

2023

Volltextzugriff (PDF)

Acceptance and Adherence to the COMPASS Trial Drug Recommendations Following Symptomatic Carotid Endarterectomy (CEA)

Journal of vascular surgery, 2024-06, Vol.79 (6), p.e236-e237

2024

Volltextzugriff (PDF)

Patient Acceptance and Adherence to the COMPASS Trial Drug Recommendations Following Symptomatic Carotid Endarterectomy

Annals of vascular surgery, 2024-11, Vol.108, p.403-409

2024

Volltextzugriff (PDF)

Cost-Effectiveness of Aldosterone Antagonists for the Treatment of Post–Myocardial Infarction Heart Failure

Value in health, 2012-05, Vol.15 (3), p.420-428

2012

Volltextzugriff (PDF)

Improving secondary prevention in patients with acute coronary syndrome through electronic prescribing plans, a quality improvement project

Clinical medicine (London, England), 2024-04, Vol.24, p.100157, Article 100157

2024

Volltextzugriff (PDF)

Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic

European journal of preventive cardiology, 2021-12, Vol.28 (14), p.1599

2021

Volltextzugriff (PDF)

Drug-eluting stents and glycoprotein IIb/IIIa inhibitors: Combination therapy for the future

The American heart journal, 2003-10, Vol.146 (4), p.S13-S17

2003

Volltextzugriff (PDF)

Real‐world data on the incidence, mortality, and cost of ischaemic stroke and major bleeding events among non‐valvular atrial fibrillation patients in England

Journal of evaluation in clinical practice, 2021-02, Vol.27 (1), p.119-133

2021

Volltextzugriff (PDF)

Perceived vs. objective frailty in patients with atrial fibrillation and impact on anticoagulant dosing: an ETNA-AF-Europe sub-analysis

Europace (London, England), 2022-10, Vol.24 (9), p.1404-1411

2022

Volltextzugriff (PDF)

Behavioral Science: Enhancing Our Approach to the Development of Effective Additional Risk Minimization Strategies

Drug safety, 2024-08, Vol.47 (8), p.733-743

2024

Volltextzugriff (PDF)

Remote monitoring after recent hospital discharge in patients with heart failure: a systematic review and network meta-analysis

Heart (British Cardiac Society), 2013-12, Vol.99 (23), p.1717-1726

2013

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(120)
Mit Volltextzugriff
(115)

Publikationsform

Sprache

Englisch
(127)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Humans
(77)
Science & Technology
(75)
Life Sciences & Biomedicine
(74)
Cardiac & Cardiovascular Systems
(47)
Cardiovascular System & Cardiology
(47)
Female
(43)
Male
(42)
Aged
(35)
Middle Aged
(34)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Treatment Outcome
(22)
Cost-Benefit Analysis
(17)
Stents
(17)
Mortality
(16)
Cardiology. Vascular System
(15)
Follow-Up Studies
(14)
Platelet Aggregation Inhibitors - Therapeutic Use
(14)
Prospective Studies
(13)
Risk Factors
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Predicting atrial fibrillation in primary care using machine learning

Real-World Associations of Renin-Angiotensin-Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New-Onset Chronic Kidney Disease or Heart Failure in the United Kingdom

Validation of a deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from UK Biobank

Protecting blinded trials in electronic hospital systems

Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK

Comparison of Bayesian model averaging and stepwise methods for model selection in logistic regression

Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink

The value of maintaining normokalaemia and enabling RAASi therapy in chronic kidney disease

Development of delivery indicators and delivery enablers for cardiovascular disease in the UK: a modified Delphi study

Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe study

Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe)

Shining a light on an additional clinical burden: work-related digital communication survey study – COVID-19 impact on NHS staff wellbeing

Fondaparinux versus Enoxaparin in non–ST-elevation acute coronary syndromes: Short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial

Using machine learning to predict anticoagulation control in atrial fibrillation: A UK Clinical Practice Research Datalink study

Nebulized Recombinant Tissue Plasminogen Activator (rt-PA) for Acute COVID-19-Induced Respiratory Failure: An Exploratory Proof-of-Concept Trial

Acceptance and Adherence to the COMPASS Trial Drug Recommendations Following Symptomatic Carotid Endarterectomy (CEA)

Patient Acceptance and Adherence to the COMPASS Trial Drug Recommendations Following Symptomatic Carotid Endarterectomy

Cost-Effectiveness of Aldosterone Antagonists for the Treatment of Post–Myocardial Infarction Heart Failure

Improving secondary prevention in patients with acute coronary syndrome through electronic prescribing plans, a quality improvement project

Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic

Drug-eluting stents and glycoprotein IIb/IIIa inhibitors: Combination therapy for the future

Real‐world data on the incidence, mortality, and cost of ischaemic stroke and major bleeding events among non‐valvular atrial fibrillation patients in England

Perceived vs. objective frailty in patients with atrial fibrillation and impact on anticoagulant dosing: an ETNA-AF-Europe sub-analysis

Behavioral Science: Enhancing Our Approach to the Development of Effective Additional Risk Minimization Strategies

Remote monitoring after recent hospital discharge in patients with heart failure: a systematic review and network meta-analysis

Suchergebnisse filtern